Recently, Suzhou Intucon Medical Technology Co., Ltd. (hereafter referred to as "Intucon"), the global leader in electric surgical staplers, announced the completion of a RMB 100-million-level Series D funding round. This round was led by Qiming Venture Partners, with co-investments from Yuanhe Holdings, Yuanhe Chencun, and Yuansheng Venture Capital.

The funds from this round of financing will continue to be allocated toward R&D of Yingtukang's innovative products, clinical studies, and market promotion, as well as investments in renovating new office and production facilities and purchasing the equipment needed for operations.

Founded in 2015, Yingtukang is a high-tech company specializing in innovative surgical products. The company is committed to becoming China's most dynamic and innovative surgical instrument manufacturer. As the world’s first company to introduce a comprehensive line of electric, smart staplers, Yingtukang now holds a unique technological edge in this niche market, positioning itself as one of the three dominant players alongside Johnson & Johnson and Medtronic.

Driven by a deep understanding of consumer needs, IntoCare continuously pioneers product innovation—hence the origin of the company’s English name, IntoCare (Insight and Innovation to Caring).

The founding team of Yingtukang, along with its R&D and technology teams, previously worked at renowned multinational corporations, bringing extensive industry experience to the table. From day one, Yingtukang established a seven-year product development pipeline, focusing on three key product lines. Over time, these products have consistently achieved new milestones:

● In October 2018, Intucon’s full range of electric staplers received ISO13485 system certification.

● In March 2020, Intucan’s entire range of electric staplers received EU CE certification;

● In September 2020, Intucon obtained the first domestic Class III registration certificate for an electric tubular stapler issued by the National Medical Products Administration of China.

● In May 2021, Intouch Medical received the Class III registration certificate from China's National Medical Products Administration for its disposable electric laparoscopic linear cutting stapler.

The aforementioned milestone also marks the official, groundbreaking launch of IntuCon’s comprehensive platform-based electric solution. This solution not only enables intelligent interaction among various types of staplers, fully "smartifying" gastrointestinal and pulmonary surgeries, but also signals the entry of domestically produced staplers into a new era of fully intelligent electronic control—ushering in smarter advancements for the medical industry.

According to available data, staplers—widely used as surgical instruments—are extensively applied in various types of surgical procedures. As highlighted in the "2021-2026 Stapler Industry Supply-Demand Research and Investment Opportunity Strategic Report" by Beijing Puhua Youce Information Consulting Co., Ltd., China's stapler market size grew from 4.827 billion yuan in 2015 to 9.479 billion yuan in 2019, reflecting a compound annual growth rate of approximately 18%. Furthermore, the report projects that China's demand for staplers will reach 19.058 billion yuan by 2024, with an estimated compound growth rate of about 15% between 2019 and 2024.

In response to evolving market dynamics, Yingtukang continuously drives technological innovation and product development. As of May 2021, Yingtukang had filed 277 patent applications, with nearly 60% being invention patents, and has been granted 117 patents in total. Backed by robust R&D capabilities and a wide range of certifications, Yingtukang’s products are now exported globally, reaching regions such as the EU, the Middle East, Africa, and North America. Domestically, these products are already in use at several renowned hospitals and have earned high praise, even standing out successfully in bidding processes across multiple provinces.

Ms. Zhang Hui, President of Intucon, stated, "Since its establishment, Intucon has been committed to empowering doctors with exceptional, innovative products that better serve patients—both in China and around the globe. After six years of dedicated development, Intucon has successfully reshaped the global perception of Chinese surgical instruments through 'Made in China' innovation. Today, our company’s fully developed range of electric staplers is at the forefront of the industry and has earned unanimous recognition from peers. Looking ahead, Intucon will continue upholding the spirit of 'insightful understanding of needs and independent innovation,' striving to deliver smarter, more convenient, and highly efficient products and services to both doctors and patients—and ultimately becoming a world-class, industry-leading enterprise."

Mr. Hu Xubo, Managing Partner at Qiming Venture Partners, stated: "Qiming Venture Partners has been investing in and supporting Endeavor Medical since its early stages. We’ve witnessed the company’s relentless exploration and dedication in the field of electric surgical staplers. Today, Endeavor Medical’s electric stapler products have achieved globally leading performance, proving that Chinese startups can indeed build world-class competitiveness in product design. Electric staplers are poised to fully leverage their superior advantages in surgical procedures, gradually securing a dominant position in the market. Endeavor Medical has systematically established a robust R&D platform and commercialization framework with strong core competencies, while also embarking on an ambitious journey toward international expansion. At this pivotal moment, we’ve chosen to reinvest and further support Endeavor Medical’s continued growth and success."

Mr. Li Huajie, Senior Partner at Yuanhe Chencun, stated: "The founding team of IntuCon has demonstrated a deep understanding of the advantages offered by electric staplers, leveraging this insight to develop innovative products tailored to a vast market opportunity—ultimately benefiting patients both domestically and internationally. As a company committed to crafting exceptional products with a true artisanal spirit, we firmly believe IntuCon possesses the unique potential to become a leader in this field. Our joint investment in IntuCon alongside our key GP, Qiming Venture Partners, is yet another successful embodiment of Yuanhe Chencun's philosophy—to identify, nurture, and accompany outstanding fund management teams. It also underscores our ongoing support for the exceptional companies already backed by Yuanhe’s venture capital funds. We look forward to this collaboration further expanding and enriching Yuanhe Chencun’s investment ecosystem, while leveraging our own financial and industry expertise to provide sustained backing to the company."